The implications of diabetes control and complications trial for the pharmacy profession

Annals of Pharmacotherapy

Volumn 30, Issue 3, 1996, Pages 294-295

  Carlisle, Betsy A ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; FOLLOW UP; HEALTH PROGRAM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; NOTE; PATIENT COUNSELING; PATIENT EDUCATION; PHARMACIST; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; ATTITUDE OF HEALTH PERSONNEL; DIABETES MELLITUS, TYPE 1; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION; PHARMACEUTICAL SERVICES;

EID: 0029921792     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603000316     Document Type: Article

References (8)

1. Diabetes 1993 vital statistics. Alexandria, VA: American Diabetes Association, 1993;341:1306-9.
2. Wang PH. Lau J, Chalmers T. Meta-analysis of effects of intensive blood glucose control on late complications of type I diabetes. Lancet 1993;341:1306-9.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of ions-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
4. Brancati FL. The benefits of tight glycemic control in diabetes mellitus: for the many or for the few (editorial)? Arch Intern Med 1995;155:665-7.
5. Vajdos MA, Gilliland PF. Does normalization of blood glucose reduce the complications of diabetes? South Med J 1995;88:372-5.
6. Santiago J. Lessons from the Diabetes Control and Complications Trial (editorial). Diabetes 1993;42:1549.
7. Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996;30:238-43.
8. ADA Position Statement. Implications of the Diabetes Control and Complications Trial. Diabetes Care 1993;16:1517.